[ad_1]
The Ministry of Health rejects critics and claims that manufacturers are chaotic because they would like to go back to the old order, which allowed them to earn more by selling drugs.
In July, the refundable drug tariff was renewed each quarter in July.
However, the chairman of the board of directors of the Association of Pharmaceutical Manufacturers Darius Sinkevičius says that under the new procedure, the number of preparations falls in the price list, which makes them insufficient for patients.
Photo Reuters / Scanpix / Tabs and Capsules
"It's clear that the current requirements for reimbursable medicines to stay for one drug is too stringent" According to him, there are currently 4 to 5 drugs against the drug. Urinary incontinence, prostate, heart disease and hypertension, according to D.Sinkevicius. preparations may fail over the next two weeks, and alternatives to all these drugs will not be compensated
"The solution would be that there should be a greater number of drug manufacturers in the price of drugs to provide the drug, "said the president of the board of directors
drug manufacturers are promoting routine problems in order to discredit the new pricing rules for reimbursable drugs.
"You have to realize that this drug supply mechanism is alive – it has always been, and no one has written about it, but since the new regime came into force and do not like manufacturers because of the need to reduce the prices of drugs, they try to show that this order is bad. politician
According to her, whenever she sees that it There may be a shortage of certain refundable medicines on the market, the price list is adjusted.
Mato Maisonio / 15min Department
K. Guruoliņa a argues that in this case, patients will not be able to receive drugs.
"This price adjustment is such a routine. He is alive – some drugs fall, others engage, but patients receive treatment as needed. The drug manufacturers also criticize the department that the price of reimbursable drugs is approved each time before it comes into effect two weeks and is not enough to properly prepare for the supply of drugs.
K. Garuolienė argued that this criticism was unreasonable, as the manufacturer still discovers whether its drugs will be evaluated.
"Manufacturers submit an application and submit an application must physically have the drugs that they will provide," she said. The State Patient Fund (VLK) has announced that a total of 2,050 drugs have been added to the new list of reimbursable medicines that came into effect on July 1. According to the VLK, the basic price of the drug has decreased by 552, and the cost of any product has not increased.
[ad_2]
Source link
